BioSpace News Archive

Deals

Pasithea Therapeutics Announces Intention to Commence a $4.0 Million Tender Offer for its Common Stock at Price of $0.70 per Share in CashTender Offer Expected to Close Third Quarter of 2023

Pasithea Therapeutics Corp. today announced that its Board of Directors (the “Board”) has authorized the repurchase, through a $4.0 million tender offer (“Tender Offer”), of up to approximately 5.7 million shares.

July 20, 2023
·
4 min read
BioMidwest

KromaTiD Launches directional Genomic Hybridization (dGH) in-Site™ DNA Probes, Expanding Access for Cell and Gene Therapy Research Programs

KromaTiD announced the launch of over 300 centromere, telomere and gene probes for use in directional Genomic Hybridization in-Site™ assays.

July 20, 2023
·
2 min read
Altamira Therapeutics and Pharma Nordic Collaborate for Marketing and Distribution of Bentrio in Scandinavia

Altamira Therapeutics Ltd. announced that it has entered into an exclusive agreement with Pharma Nordic AS for the marketing and distribution of Bentrio®, a nasal spray for protection against airborne allergens, in Norway and potentially further Scandinavian countries.

July 20, 2023
·
4 min read
Drug Development

Palvella Therapeutics Announces Planned Pivotal Phase 3 Study Design of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations

Palvella Therapeutics, Inc. today announced the planned pivotal Phase 3 study design of QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin), a topical mTOR inhibitor and the lead product candidate from the QTORIN™ platform, in Microcystic Lymphatic Malformations (Microcystic LMs).

July 20, 2023
·
9 min read
Business

Zynex, Inc. Sets Second Quarter 2023 Earnings Call

Zynex, Inc. will hold a conference call on Thursday, July 27, 2023 at 4:15 PM Eastern Time to discuss its financial results for the second quarter, 2023 ended June 30, 2023.

July 20, 2023
·
1 min read
FDA

New FDA-Approved Treatment for Rett Syndrome Spurs Calls for Education, Innovation

The Clinical Neurological Society of America released a new expert-led clinical proceedings paper, “Rett Syndrome: A Devastating Neurodevelopmental Disorder.” FDA approval of the first medication for Rett syndrome elevates the need for further education and innovation, the paper’s authors explain.

July 20, 2023
·
2 min read
Biotech Bay

Nusano to Participate in Isotope and Radiopharmaceutical Conferences

Nusano, Inc. today announced participation in two conferences in July 2023. Nusano CEO Chris Lowe will present an overview of the company’s breakthrough radioisotope production platform at the 2nd Annual Targeted Radiopharmaceuticals Summit on July 26 in Boston.

July 20, 2023
·
1 min read
Genetown

Replimune Announces Sander Slootweg will Depart from its Board of Directors

Replimune Group, Inc. announced Sander Slootweg, founder and managing partner at Forbion, will not seek to be reappointed as a non-executive director at the end of his current term at the company’s upcoming annual general meeting.

July 20, 2023
·
3 min read
Biotech Bay

Teknova and Sartorius BIA Separations Share Data Demonstrating Reliable and Scalable Approach for the Enhancement of AAV Full Capsid Enrichment with an Optimized AEX Platform

Alpha Teknova, Inc., and Sartorius BIA Separations, which is part of the international life science group Sartorius, shared new data that demonstrates the ability to improve the recovery of full AAV capsids during anion-exchange purification, which will help gene therapy companies streamline the downstream processing workflow.

July 20, 2023
·
4 min read
Drug Development

Promontory Therapeutics Expands Phase 2 Trial of PT-112 in Metastatic Castrate-Resistant Prostate Cancer to France

Promontory Therapeutics Inc. has expanded its clinical presence to France.

July 20, 2023
·
4 min read